Hannah M Kerman1, Savannah R Smith1, Karen C Smith1, Jamie E Collins2, Lisa G Suter3, Jeffrey N Katz2, Elena Losina2. 1. Orthopaedic and Arthritis Center for Outcomes Research Policy and Innovation Evaluation in Orthopaedic Treatments Center, Boston, Massachusetts. 2. Orthopaedic and Arthritis Center for Outcomes Research Policy and Innovation Evaluation in Orthopaedic Treatments Center, and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 3. Yale-New Haven Hospital Center for Outcomes Research and Evaluation, and Yale School of Medicine, New Haven, Connecticut.
Abstract
OBJECTIVE: Total knee replacement (TKR) is an effective treatment for end-stage knee osteoarthritis (OA). American racial minorities undergo fewer TKRs than whites. We estimated quality-adjusted life-years (QALYs) lost for African American knee OA patients due to differences in TKR offer, acceptance, and complication rates. METHODS: We used the Osteoarthritis Policy Model, a computer simulation of knee OA, to predict QALY outcomes for African American and white knee OA patients with and without TKR. We estimated per-person QALYs gained from TKR as the difference between QALYs with current TKR use and QALYs when no TKR was performed. We estimated average, per-person QALY losses in African Americans as the difference between QALYs gained with white rates of TKR and QALYs gained with African American rates of TKR. We calculated population-level QALY losses by multiplying per-person QALY losses by the number of persons with advanced knee OA. Finally, we estimated QALYs lost specifically due to lower TKR offer and acceptance rates and higher rates of complications among African American knee OA patients. RESULTS: African American men and women gain 64,100 QALYs from current TKR use. With white offer and complications rates, they would gain an additional 72,000 QALYs. Because these additional gains are unrealized, we call this a loss of 72,000 QALYs. African Americans lose 67,500 QALYs because of lower offer rates, 15,800 QALYs because of lower acceptance rates, and 2,600 QALYs because of higher complication rates. CONCLUSION: African Americans lose 72,000 QALYs due to disparities in TKR offer and complication rates. Programs to decrease disparities in TKR use are urgently needed.
OBJECTIVE: Total knee replacement (TKR) is an effective treatment for end-stage knee osteoarthritis (OA). American racial minorities undergo fewer TKRs than whites. We estimated quality-adjusted life-years (QALYs) lost for African American knee OA patients due to differences in TKR offer, acceptance, and complication rates. METHODS: We used the Osteoarthritis Policy Model, a computer simulation of knee OA, to predict QALY outcomes for African American and white knee OA patients with and without TKR. We estimated per-person QALYs gained from TKR as the difference between QALYs with current TKR use and QALYs when no TKR was performed. We estimated average, per-person QALY losses in African Americans as the difference between QALYs gained with white rates of TKR and QALYs gained with African American rates of TKR. We calculated population-level QALY losses by multiplying per-person QALY losses by the number of persons with advanced knee OA. Finally, we estimated QALYs lost specifically due to lower TKR offer and acceptance rates and higher rates of complications among African American knee OA patients. RESULTS: African American men and women gain 64,100 QALYs from current TKR use. With white offer and complications rates, they would gain an additional 72,000 QALYs. Because these additional gains are unrealized, we call this a loss of 72,000 QALYs. African Americans lose 67,500 QALYs because of lower offer rates, 15,800 QALYs because of lower acceptance rates, and 2,600 QALYs because of higher complication rates. CONCLUSION: African Americans lose 72,000 QALYs due to disparities in TKR offer and complication rates. Programs to decrease disparities in TKR use are urgently needed.
Authors: Said A Ibrahim; Roslyn A Stone; Xiaoyan Han; Peter Cohen; Michael J Fine; William G Henderson; Shukri F Khuri; C Kent Kwoh Journal: Arthritis Rheum Date: 2005-10
Authors: Kelli D Allen; Jiu-Chiuan Chen; Leigh F Callahan; Yvonne M Golightly; Charles G Helmick; Jordan B Renner; Todd A Schwartz; Joanne M Jordan Journal: J Rheumatol Date: 2011-12-01 Impact factor: 4.666
Authors: Heejung Bang; Ya-lin Chiu; Stavros G Memtsoudis; Lisa A Mandl; Alejandro González Della Valle; Alvin I Mushlin; Robert G Marx; Madhu Mazumdar Journal: Am J Orthop (Belle Mead NJ) Date: 2010-09
Authors: Elena Losina; Rochelle P Walensky; William M Reichmann; Holly L Holt; Hanna Gerlovin; Daniel H Solomon; Joanne M Jordan; David J Hunter; Lisa G Suter; Alexander M Weinstein; A David Paltiel; Jeffrey N Katz Journal: Ann Intern Med Date: 2011-02-15 Impact factor: 25.391
Authors: Jeffrey N Katz; Jane Barrett; Nizar N Mahomed; John A Baron; R John Wright; Elena Losina Journal: J Bone Joint Surg Am Date: 2004-09 Impact factor: 5.284
Authors: K D Allen; C G Helmick; T A Schwartz; R F DeVellis; J B Renner; J M Jordan Journal: Osteoarthritis Cartilage Date: 2009-03-18 Impact factor: 6.576
Authors: J N Katz; S R Smith; J E Collins; D H Solomon; J M Jordan; D J Hunter; L G Suter; E Yelin; A D Paltiel; E Losina Journal: Osteoarthritis Cartilage Date: 2015-10-23 Impact factor: 6.576
Authors: Walter Klyce; Daniel Badin; Jigar S Gandhi; R Jay Lee; B David Horn; Erin Honcharuk Journal: J Child Orthop Date: 2022-05-10 Impact factor: 1.917
Authors: Joseph Atarere; Emeka Agudile; Vwaire Orhurhu; Ukamaka M Agudile; George Sorescu; Zakari Aliyu Suleiman; Michael J Weaver; Arvind Von Keudell Journal: JB JS Open Access Date: 2022-09-14
Authors: Emma E Williams; Jeffrey N Katz; Valia P Leifer; Jamie E Collins; Tuhina Neogi; Lisa G Suter; Bruce Levy; Alexander Farid; Clare E Safran-Norton; A David Paltiel; Elena Losina Journal: ACR Open Rheumatol Date: 2022-07-21
Authors: Caroline P Thirukumaran; Xueya Cai; Laurent G Glance; Yeunkyung Kim; Benjamin F Ricciardi; Kevin A Fiscella; Yue Li Journal: J Bone Joint Surg Am Date: 2020-12-16 Impact factor: 6.558